Do I need to highlight this for you... SO THERE ARE 422,316,252 SHARES OF COMMON STOCK ISSUED AND OUTSTANDINGLOLOLOL.... what part of this is hard to understand...ALSO NOTICE THE WORDS PRE REVERSE...LOL
As of October 15, 2013, 422,316,252 shares of common stock were issued and outstanding out of 1,000,000,000 shares outstanding. Additionally, 90,750,435 shares of common stock are subject to outstanding options and warrants. Pursuant to an Agreement and Plan of Merger dated as of September 30 2013, among the Company, Hygeia Therapeutics, Inc. (“Hygeia”), Canterbury Laboratories, LLC (“Canterbury”), and certain other parties, the Company agreed to acquire all of the equity interests of Canterbury and Hygeia held by the holders thereof for 115,011,563 pre-reverse split shares of the Company’s common stock. Additionally, the Company and Histogen, Inc. (“Histogen”) have executed a non-binding letter of intent pursuant to which the Company agreed to acquire all of the capital stock of Histogen for 350,000,000 pre-reverse split shares of the Company’s common stock. In connection with the acquisition of Canterbury/Hygeia and Histogen and the extinguishment of the Company’s liabilities, the Company intends to conduct private placements of its securities (the “Private Placements”) requiring the issuance of additional shares of common stock and/or securities convertible into or exercisable for common shares.
Market Data 
Markets 
